Company / Return on Equity (ROE)
VOLITIONRX LTD Return on Equity (ROE) History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-125.2%
FY2021
5-year range
-125.2% / -125.2%
FY2017-FY2021
Trend
-10.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
VOLITIONRX LTD reports negative total equity of -125.2% in FY2021. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-125.2% in FY2021.
Improved from -148.3% to -125.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, return on equity (roe) decreased 10.4% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -125.2% | -10.4% |
| FY2020 | -113.4% | +23.6% |
| FY2019 | -148.3% | +72.8% |
| FY2014 | -545.1% | -29.8% |
| FY2013 | -420.1% | -30.6% |
| FY2012 | -321.6% | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026